COMMUNIQUÉS West-GlobeNewswire

Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support
07/05/2026
Survey of more than 3,000 GLP‑1 patients reveals care gaps and rising out‑of‑pocket costs, underscoring employers’ need to pair flexible GLP‑1 access with ongoing lifestyle support SAN FRANCISCO, May 07, 2026 (GLOBE [...]
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
07/05/2026
Jazz announced U.S. FDA acceptance with Priority Review of Supplemental Biologics License Application (sBLA) for zanidatamab in first-line HER2-positive unresectable locally advanced or metastatic gastroesophageal [...]
LifeStance Health Group Announces Launch of Secondary Public Offering
07/05/2026
SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
LeMaitre to Present at the Bank of America Healthcare Conference
07/05/2026
BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM [...]
VitalHub Reports First Quarter 2026 Results
07/05/2026
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 34% YoY to $99.1 million Total Revenue up 47% YoY to $31.9 million Adjusted EBITDA⁽¹⁾ up 42% YoY to $8.0 million TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI [...]
Nova Leap Health Corp. Posts Q1 2026 Results
07/05/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 07, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
07/05/2026
Six-Month Clinical Data Demonstrate Restoration of Cone-Mediated Vision in Pediatric LCA5 Patients, with Sensitivity Improvements Reaching Normal Ranges Early BEST1 Data Show Visual Acuity Gains and Improved Retinal [...]
Tarsus to Participate in Upcoming Investor Conferences
07/05/2026
IRVINE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: Bank of America [...]
NetraMark Announces Change To Board Of Directors
07/05/2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
MALVERN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
07/05/2026
Reported positive results from aleniglipron Phase 2 ACCESS II study with up to 16.3% body weight loss, demonstrating highest efficacy among oral GLP-1RAs at the 44-week time point and potentially comparable efficacy to [...]
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call
07/05/2026
ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced [...]
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
07/05/2026
Interim biomarker-rich Phase 1 data for JADE101 to be featured in an oral session at the 63rd European Renal Association Congress Phase 2 trial of JADE101 in IgA nephropathy patients expected to begin in the second [...]
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
07/05/2026
-- Topline data from randomized Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expected in 2H26 -- -- Systemic lung cancer programs advancing with additional updates expected throughout 2026 [...]
STERIS Appoints Pierre Boulud to Board of Directors
07/05/2026
DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
CONSHOHOCKEN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis [...]
ICU Medical Announces First Quarter 2026 Results
07/05/2026
SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update
07/05/2026
- Positive data announced from Phase 1 Dose Expansion Study of varsetatug masetecan (“Varseta-M”) EpCAM PROBODY® ADC in Patients with Advanced Colorectal Cancer (CRC) - - Enrollment of 40 patients in Varseta-M Dose [...]
Extendicare Announces 2026 First Quarter Results
07/05/2026
MARKHAM, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2026. First Quarter 2026 Highlights Adjusted [...]

Pages